Foundation Medicine Executive and Leadership Team

Archana Murali, the Director, Corporate Strategy & Chief Executive Officer, Office of at Foundation Medicine, directs long-term growth initiatives and strategic planning. Murali architects the overarching business roadmap, ensuring alignment between molecular profiling capabilities and clinical research objectives. By analyzing market trends in precision oncology, the Director, Corporate Strategy & Chief Executive Officer, Office of identifies opportunities for expanding the reach of genomic testing services. This leadership role involves coordinating with cross-functional teams to optimize the delivery of diagnostic insights to healthcare providers. Archana Murali maintains a focus on scaling operations to meet the evolving needs of the global cancer community. Through rigorous evaluation of competitive landscapes, the Director, Corporate Strategy & Chief Executive Officer, Office of secures the company's position as a leader in molecular diagnostics. This strategic oversight drives the development of innovative solutions that improve patient outcomes across diverse clinical settings.

Dominique Schutz, the Chief Financial Officer & Head of Corporate Management at Foundation Medicine, directs financial planning, capital allocation, and corporate governance. Schutz architects the fiscal strategy that supports the company's investment in molecular profiling technology and research infrastructure. By overseeing financial reporting and risk management, the Chief Financial Officer & Head of Corporate Management ensures the long-term sustainability of the business model. This role involves collaborating with the Board and executive leadership to evaluate investment opportunities in precision medicine. Dominique Schutz manages corporate management functions to ensure compliance and operational transparency. Through the optimization of financial resources, the Chief Financial Officer & Head of Corporate Management drives the growth of diagnostic services and clinical research programs. This leadership position remains essential for maintaining the financial health required to advance the standard of care for cancer patients through innovative genomic solutions.

Beatriz Garcia-Madrid, the Executive Business Partner To the Chief Operating Officer at Foundation Medicine, manages high-level operational workflows and executive communications. Garcia-Madrid facilitates the execution of daily business priorities, ensuring the Chief Operating Officer maintains focus on core molecular profiling initiatives. By streamlining administrative processes and project management, the Executive Business Partner To the Chief Operating Officer enhances organizational efficiency across the company. This role involves bridging communication gaps between leadership and internal departments to ensure seamless operational continuity. Beatriz Garcia-Madrid monitors key performance indicators to track the success of internal programs designed to support precision medicine research. Through proactive problem-solving and resource allocation, the Executive Business Partner To the Chief Operating Officer supports the scaling of diagnostic services. This position remains vital for maintaining the operational rigor required to deliver high-quality genomic data to clinical partners worldwide.

Rachel von Staats, the Director, Office of the Chief Operating Officer at Foundation Medicine, oversees the integration of operational strategies and cross-departmental projects. von Staats manages the execution of initiatives that support the company's molecular profiling services and clinical research partnerships. By coordinating the activities of the Chief Operating Officer's office, the Director, Office of the Chief Operating Officer ensures that organizational goals remain aligned with the broader mission of precision cancer care. This role involves monitoring operational metrics to identify areas for process improvement and efficiency gains. Rachel von Staats facilitates communication between executive leadership and operational teams to drive consistent performance across all business units. Through the management of complex workflows, the Director, Office of the Chief Operating Officer enables the company to maintain high standards of quality and scientific rigor. This position supports the expansion of diagnostic capabilities to meet the needs of the global oncology community.

Kierstin Smolinski, the Senior Director, People Operations & Organizational Development Chief of Staff at Foundation Medicine, designs talent strategies and organizational frameworks. Smolinski architects programs that foster scientific excellence and professional growth within the workforce. By aligning human capital initiatives with the company's mission in molecular profiling, the Senior Director, People Operations & Organizational Development Chief of Staff ensures the organization attracts and retains top-tier talent. This role involves managing complex organizational development projects that support the scaling of research and development functions. Kierstin Smolinski collaborates with leadership to refine internal culture and operational effectiveness. Through the implementation of data-driven people strategies, the Senior Director, People Operations & Organizational Development Chief of Staff optimizes team performance. This leadership function directly impacts the company's ability to innovate in the competitive field of precision oncology by maintaining a highly skilled and motivated workforce.

Andrew Suchoff, the Chief People Officer at Foundation Medicine, leads the global human resources strategy and organizational culture initiatives. Suchoff architects programs that promote diversity, equity, and inclusion while supporting the scientific mission of the company. By overseeing talent acquisition, leadership development, and employee engagement, the Chief People Officer ensures the organization maintains a competitive edge in the biotechnology sector. This role involves aligning workforce capabilities with the evolving demands of precision oncology research and clinical care. Andrew Suchoff collaborates with other C-suite leaders to foster an environment of innovation and scientific excellence. Through the implementation of comprehensive people strategies, the Chief People Officer drives organizational performance and employee retention. This leadership function supports the company's ability to attract the expertise necessary to advance molecular profiling and deliver actionable insights to physicians and researchers across the globe.

Winifred Lynn Swan, the General Counsel & Chief Legal Officer at Foundation Medicine, manages all legal affairs, regulatory compliance, and intellectual property strategy. Swan architects the legal framework that protects the company's proprietary molecular profiling technologies and research data. By overseeing interactions with regulatory bodies, the General Counsel & Chief Legal Officer ensures that all diagnostic services meet the highest standards of quality and safety. This role involves providing strategic counsel to the Board and executive team on complex legal matters related to clinical research and market expansion. Winifred Lynn Swan mitigates risk while enabling the company to pursue innovative partnerships in the cancer community. Through the management of legal operations, the General Counsel & Chief Legal Officer supports the company's mission to provide precision cancer care. This position remains critical for navigating the regulatory landscape and securing the company's intellectual assets.

Lisa Brien, the Senior Administrative Partner at Foundation Medicine, coordinates executive support and manages complex administrative operations. Brien facilitates the daily activities of senior leadership, ensuring that time and resources remain focused on strategic priorities in molecular profiling. By optimizing scheduling, communication, and project coordination, the Senior Administrative Partner enhances the overall productivity of the executive team. This role involves managing sensitive information and supporting the execution of high-level business initiatives. Lisa Brien acts as a central point of contact for internal and external stakeholders, ensuring smooth operations across the organization. Through the management of administrative workflows, the Senior Administrative Partner supports the company's ability to deliver precision cancer care solutions efficiently. This position remains vital for maintaining the operational rhythm required to support the company's mission of advancing clinical research and improving patient outcomes on a global scale.